SCHEDULE 13G 0001373604 XXXXXXXX LIVE Common stock, par value $0.0001 per share 03/21/2025 0001783032 Elevation Oncology, Inc. 28623U101 101 Federal Street, Suite 1900 Boston MA 02110 Rule 13d-1(c) BML Investment Partners, L.P. b DE 0 5890934 0 5890934 5890934 N 9.9 PN Elevation Oncology, Inc. 101 Federal Street, Suite 1900, Boston, Massachusetts, 02110 BML Investment Partners, L.P. 65 E Cedar - Suite 2, Zionsville IN 46077 Delaware Y 5890934 9.9 0 5890934 0 5890934 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. BML Investment Partners, L.P. Braden M Leonard 03/26/2025 BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.